Review article: Hepatitis C virus infection and type-2 diabetes mellitus in renal diseases and transplantation

Alimentary Pharmacology and Therapeutics

Volumn 21, Issue 6, 2005, Pages 623-632

  Fabrizi, F ^a,d   Lampertico, P ^a   Lunghi, G ^a   Mangano, S ^b   Aucella, F ^c   Martin, P ^d  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Nephrology Units at Coma Hospital   (Italy)

^c Department of Radiology   (Italy)

^d MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; GLUTAMATE DECARBOXYLASE ANTIBODY; HEPATITIS C ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PANCREAS ISLET CELL ANTIBODY; TACROLIMUS;

COHORT ANALYSIS; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GLOMERULONEPHRITIS; GLUCOSE INTOLERANCE; GRAFT SURVIVAL; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANTIVIRAL AGENTS; DIABETES MELLITUS, TYPE 2; HEPATITIS C, CHRONIC; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE;

EID: 16344378628     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02389.x     Document Type: Review

References (64)

1. Tokars JI, Finelli L, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2001. Semin Dial 2004; 17: 310-9.
2. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3-10.
3. Ferri C, Greco F, Longombardo G, et al. Association between hepatitis C and mixed essential cryoglobulinemia. Clin Exp Rheumatol 1991; 9: 621-4.
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-5.
5. Casato M, Pucillo LP, Laganà B, Taliani G, Goffredo F. Cryoglobulinemia and hepatitis C virus. Lancet 1991; 33: 1047-8 (letter).
6. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990; 162: 569-70.
7. Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-6.
8. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-70.
9. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994; 330: 751-6.
10. Stehman-Breen C, Alpers CE, Couser WG, Willson R, Johnson RJ. Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol 1995; 44: 141-7.
11. D'Amico G, Fornasieri A. Cryoglobulinemic glomerulonephritis: a membranoproliferative glomerulonephritis induced by hepatitis C virus. Am J Kidney Dis 1995; 25: 361-9.
12. Mackie FD, Peakman M, Yun MA, et al. Primary and secondary liver kidney microsomal autoantibodies response following infection with hepatitis C. Gastroenterology 1994; 106: 1672-5.
13. Borque L, Elena A, Maside C. Rheumathoid arthritis and hepatitis C virus antibodies. Clin Exp Rheumatol 1991; 9: 617-9.
14. Ueno Y, Kinoshita R, Kishimoto I, Okamoto S. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994; 33: 289-91.
15. Irving WL, Day S, Johnston ID. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 1993; 148: 1683-4.
16. Prati D, Poli F, Farma E, et al. North Italy Transplant Program (NITP). Multicenter study on hepatitis C virus infection in patients with dilated cardiomiopathy. J Med Virol 1999; 58: 116-20.
17. Teragaki M, Nishiguchi S, Takeuchi K, Yoshiyama M, Akioka K, Yoshikawa J. Prevalence of hepatitis C virus infection among patients with hypertrophic cardiomiopathy. Heart Vessels 2003; 18: 167-70.
18. Matsumori A, Ohashi N, Hasegawa K, et al. Hepatitis C virus infection and heart diseases: a multicenter study in Japan. Jpn Circ 1998; 62: 389-91.
19. Jubert C, Pawlotsky JM, Pouget F, et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 1994; 130: 73-6.
20. Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997; 92: 3-17.
21. King PD, McMurray RW, Becherer PR. Sjögren syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 1994; 89: 1047-50.
22. Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994; 84: 3047-53.
23. Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 92: 1275-9.
24. Mele A, Pulsoni A, Bianco E, et al. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 2003; 102: 996-9.
25. Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocites after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 89-94.
26. Duesberg PH. Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation. Proc Natl Acad Sci USA 1989; 86: 755-64.
27. Fabris P, Betterle C, Floreani A, et al. Development of type 1 diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis. Lancet 1992; 320: 548 [letter].
28. Menser MA. Rubella infection and diabetes mellitus. Lancet 1978; i: 57-60.
29. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8.
30. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/P13-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes. Hepatology 2003; 38: 1384-92.
31. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
32. Mason AL, Lau JYN, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29: 328-33.
33. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19: 998-1000.
34. Caronia S, Taylor K, Pagliaro L, et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 30: 1059-63.
35. Fraser GM, Harman I, Meller N, Niv Y, Potath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr Med Sci 1996; 32: 526-30.
36. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.
37. Ozylkan E, Arslan M. Increased prevalence of diabetes mellitus in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1996; 91: 1480-1.
38. Grimbert S, Valensi P, Levy-Marchal C, et al. High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study. Gastroenterol Clin Biol 1996; 20: 544-8.
39. Lecube A, Hernandez C, Genesca J, Esteban JI, Jardi R, Simo R. High prevalence of glucose abnormalities in patients with hepatitis C virus infection. Diabetes Care 2004; 27: 1171-5.
40. Mangia A, Schiavone G, Lezzi G, et al. HCV and diabetes mellitus: evidence for a negative association. Am J Gastroenterol 1998; 93: 2363-67.
41. Baid S, Cosimi AB, Farrell ML, et al. Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001; 72: 1066-72.
42. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transplant 2004; 10: 349-55.
43. AlDosary AA, Ramji AS, Elliott TG, et al. Post-liver transplantation diabetes mellitus: an association with hepatitis C. Liver Transplant 2002; 8: 356-61.
44. Delgado-Borrego A, Casson D, Schoenfeld D, et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004; 77: 703-10.
45. Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman S. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998; 26: 30-3.
46. Steinmuller Th, Stockmann M, Bechstein WO, Settmacher U, Jonas S, Neuhaus P. Liver transplantation and diabetes mellitus. Exp Clin Endocrinol Diabetes 2000; 108: 401-5.
47. Bigam DL, Pennington JJ, Carpenter A, et al. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000; 32: 87-90.
48. Navasa M, Bustamante J, Marroni C, et al. Diabetes mellitus after liver transplantation: prevalence and predictive factors. J Hepatol 1996; 25: 64-71.
49. Tueche SG. Diabetes mellitus after liver transplant: new etiologic clues and cornerstones for understanding. Transplant Proc 2003; 35: 1466-8.
50. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis C virus infection during long-term haemodialysis. Swiss Med Wkly 2003; 133: 611-8.
51. Soma J, Saito T, Taguma Y, et al. High prevalence and adverse effects of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 2000; 11: 690-9.
52. Batty DS, Swanson SJ, Kirk AD, Ko CW, Agodoa LY, Abbott KC. Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patients survival. Am J Transplant 2001; 1: 179-84.
53. Younossi ZM, Braun WE, Protiva DA, Gifford RW, Straffon RA. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years. Transplantation 1999; 67: 272-5.
54. Yildiz A, Tutuncu Y, Yacizi H, et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation 2002; 74: 1109-13.
55. Gentil MA, Rocha JL, Pereira P, Algarra GR, Lopez R. High incidence of diabetes mellitus after kidney transplant in patients with hepatitis C. Nephron 1999; 82: 55 [letter].
56. Gentil MA, Luna E, Rodriguez-Algarra G, et al. Incidence of diabetes mellitus requiring insulin treatment after renal transplantation in patients with hepatitis C. Nephrol Dial Transplant 2002; 17: 887-91.
57. Gentil MA, Lopez M, Gonzalez-Roncero F, et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols. Transplant Proc 2003; 35: 1748-50.
58. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002; 13: 1374-80.
59. Finni PES, Souza ERM, Rioja S, et al. Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus? Transplant Proc 2004; 36: 884-5.
60. Sens YAS, Silva VDST, Malafronte P, Souza JF, Miorin LA, Jabur P. Posttransplant diabetes mellitus in renal transplant patients with hepatitis C virus. Transplant Proc 2004; 36: 886-8.
61. Gursoy M, Guvener N, Koksal R, et al. Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients. Transplant Proc 2000; 32: 561-2.
62. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003; 3: 178-85.
63. Abbott KC, Bernet VJ, Agodoa LY, Yuan CM. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States. BMC Endocrine Disorders 2003; 3: 1-13.
64. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes. A systematic review of the literature. Diabetes Care 2002; 25: 583-92.